Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
Mom With Breast Cancer Diagnosis Starts Nonprofit to Help Others
October is Breast Awareness Cancer Month as the disease affects millions of American families. Elissa Kalver, founder of Wegotthis.org, joined Cheddar News to explain how breast cancer inspired her to create her own nonprofit and provided some details of her personal battle while maintaining a family.
New Animation of Mars
Scientists at the European Space Agency have created an animation showing Mars that's been strung together from photos of a desert canyon on the planet.
Load More